633 related articles for article (PubMed ID: 25292427)
1. Eph receptors and ephrins: therapeutic opportunities.
Barquilla A; Pasquale EB
Annu Rev Pharmacol Toxicol; 2015; 55():465-87. PubMed ID: 25292427
[TBL] [Abstract][Full Text] [Related]
2. Ephrin-Eph signaling usage by a variety of viruses.
de Boer ECW; van Gils JM; van Gils MJ
Pharmacol Res; 2020 Sep; 159():105038. PubMed ID: 32565311
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of targeting the Eph/ephrin signaling complex.
Saha N; Robev D; Mason EO; Himanen JP; Nikolov DB
Int J Biochem Cell Biol; 2018 Dec; 105():123-133. PubMed ID: 30343150
[TBL] [Abstract][Full Text] [Related]
4. Eph-ephrin bidirectional signaling in physiology and disease.
Pasquale EB
Cell; 2008 Apr; 133(1):38-52. PubMed ID: 18394988
[TBL] [Abstract][Full Text] [Related]
5. Eph receptors and ephrins in cancer: bidirectional signalling and beyond.
Pasquale EB
Nat Rev Cancer; 2010 Mar; 10(3):165-80. PubMed ID: 20179713
[TBL] [Abstract][Full Text] [Related]
6. Eph/ephrin signaling in cancer: intricate, puzzling and ... fascinating!
Alonso-Colmenar LM
Cell Adh Migr; 2012; 6(2):100-1. PubMed ID: 22814609
[TBL] [Abstract][Full Text] [Related]
7. The Functions of EphA1 Receptor Tyrosine Kinase in Several Tumors.
Wu Y; Du Z; Mou J; Qiu X; Chen J; Cai S; Ren D; Xiao F; Zhou G; Yuan C
Curr Med Chem; 2023; 30(20):2340-2353. PubMed ID: 35996244
[TBL] [Abstract][Full Text] [Related]
8. Regulation and misregulation of Eph/ephrin expression.
Arvanitis DN; Davy A
Cell Adh Migr; 2012; 6(2):131-7. PubMed ID: 22568953
[TBL] [Abstract][Full Text] [Related]
9. The role of ephrins and Eph receptors in cancer.
Surawska H; Ma PC; Salgia R
Cytokine Growth Factor Rev; 2004 Dec; 15(6):419-33. PubMed ID: 15561600
[TBL] [Abstract][Full Text] [Related]
10. Eph receptors and ephrins as targets for cancer therapy.
Xi HQ; Wu XS; Wei B; Chen L
J Cell Mol Med; 2012 Dec; 16(12):2894-909. PubMed ID: 22862837
[TBL] [Abstract][Full Text] [Related]
11. Eph receptor signaling and ephrins.
Lisabeth EM; Falivelli G; Pasquale EB
Cold Spring Harb Perspect Biol; 2013 Sep; 5(9):. PubMed ID: 24003208
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of eph receptor kinase activation in cancer cells by coexpressed ephrin ligands.
Falivelli G; Lisabeth EM; Rubio de la Torre E; Perez-Tenorio G; Tosato G; Salvucci O; Pasquale EB
PLoS One; 2013; 8(11):e81445. PubMed ID: 24348920
[TBL] [Abstract][Full Text] [Related]
13. Eph receptor and ephrin function in breast, gut, and skin epithelia.
Perez White BE; Getsios S
Cell Adh Migr; 2014; 8(4):327-38. PubMed ID: 25482622
[TBL] [Abstract][Full Text] [Related]
14. Targeting the Eph System with Peptides and Peptide Conjugates.
Riedl SJ; Pasquale EB
Curr Drug Targets; 2015; 16(10):1031-47. PubMed ID: 26212263
[TBL] [Abstract][Full Text] [Related]
15. Eph and ephrins in epithelial stem cell niches and cancer.
Genander M
Cell Adh Migr; 2012; 6(2):126-30. PubMed ID: 22568955
[TBL] [Abstract][Full Text] [Related]
16. Eph/ephrin signaling in epithelial development and homeostasis.
Miao H; Wang B
Int J Biochem Cell Biol; 2009 Apr; 41(4):762-70. PubMed ID: 18761422
[TBL] [Abstract][Full Text] [Related]
17. Role of Eph/ephrin tyrosine kinase in malignant glioma.
Nakada M; Hayashi Y; Hamada J
Neuro Oncol; 2011 Nov; 13(11):1163-70. PubMed ID: 21856686
[TBL] [Abstract][Full Text] [Related]
18. Eph receptor tyrosine kinases in cancer stem cells.
Chen J; Song W; Amato K
Cytokine Growth Factor Rev; 2015 Feb; 26(1):1-6. PubMed ID: 24933439
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic targeting of EPH receptors and their ligands.
Boyd AW; Bartlett PF; Lackmann M
Nat Rev Drug Discov; 2014 Jan; 13(1):39-62. PubMed ID: 24378802
[TBL] [Abstract][Full Text] [Related]
20. Eph/ephrin recognition and the role of Eph/ephrin clusters in signaling initiation.
Nikolov DB; Xu K; Himanen JP
Biochim Biophys Acta; 2013 Oct; 1834(10):2160-5. PubMed ID: 23628727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
